0001610618-23-000032.txt : 20230329 0001610618-23-000032.hdr.sgml : 20230329 20230329172826 ACCESSION NUMBER: 0001610618-23-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230327 FILED AS OF DATE: 20230329 DATE AS OF CHANGE: 20230329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandison Taylor CENTRAL INDEX KEY: 0001702287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 23776297 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 wf-form4_168012529430238.xml FORM 4 X0407 4 2023-03-27 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001702287 Sandison Taylor C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DR, STE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-03-27 4 A 0 90000 0 A 378550 D Employee Stock Option (right to buy) 1.01 2023-03-27 4 A 0 180000 0 A 2033-03-26 Common Stock 180000.0 180000 D Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date. The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023. /s/ Shane Ward, Attorney-in-Fact 2023-03-29